Smart Innovation

Antimicrobial resistance (AMR)
AMR develops when bacteria, fungi or viruses are exposed to antibiotics, antifungals or antivirals. As a result, the antimicrobials become ineffective and infections may persist. In addition, medical interventions including surgery, chemotherapy and stem cell therapy may become impossible.
AMR is considered the biggest global threat of Health and Food Safety.
AMR Insights
For Researchers and Entrepreneurs who wish to investigate, develop and commercialize novel vaccines, diagnostics and antimicrobials to prevent Antimicrobial resistance, AMR Insights offers selected, global information and data, specific education and extensive networking and partnering opportunities.
AMR Insights is for:
- Researchers at Universities and University Medical Centers
- Researchers at Research Institutes
- R&D professionals in Pharma, Biopharma and Diagnostics companies
- Entrepreneurs in start-up’s and spin off companies
- Innovators, Venture Capitalists.
Latest Topics
-
04 February 2025
Antimicrobial peptides: An alternative strategy to combat antimicrobial resistance
Peptides, a group of naturally occurring molecules, play a crucial role in innate immunity and antimicrobial resistance. They are considered viable alternatives for treating multidrug-resistant microbes, inflammation, and wound healing. Their broad-spectrum antibacterial activity is primarily due to membrane disruption, cell wall synthesis inhibition, and enzymatic activity.
Read more... -
03 February 2025
Intergovernmental or fully independent? Designing a scientific panel on evidence for action against antimicrobial resistance
The Scientific Panel on Evidence for Action against Antimicrobial Resistance (SPEA) aims to synthesize scientific evidence on AMR and outline policy options. Despite calls for a policy-science interface and a 2024 Political Declaration, no authoritative entity exists. The SPEA could facilitate better global coordination, establish real-time evidence, and monitor progress towards global AMR goals. The […]
Read more... -
03 February 2025
Utility of Artificial Intelligence in Antibiotic Development: Accelerating Discovery in the Age of Resistance
Antimicrobial resistance (AMR) is a global health concern, causing increased morbidity and mortality. AI can help identify antimicrobial-potent molecules and optimize drug design. This article examines AI’s benefits in antibiotic development, including time, cost, and efficiency, while also discussing challenges in biomedical implementation.
Read more...
More news related to Smart innovation